Metraipolis › archive › dc_bed120bf57f4

Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis — Europe PMC PMID:42449587

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449587
DOI
10.3390/cancers18132041
License (as archived)
solo-consultazione
Archived
2026-10-19T04:25:51.499Z
SHA-256 of the archived text
1934cb46664c15e80649dc8285df1cc8da004f34c9a327be407e601e03207d8d
Stable URL of this page
https://metraipolis.com/documento/dc_bed120bf57f4

How to cite

Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis — Europe PMC PMID:42449587 — Europe PMC (en), https://europepmc.org/article/MED/42449587 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bed120bf57f4 (Metraipolis archive dc_bed120bf57f4, sha256 1934cb46664c15e80649dc8285df1cc8da004f34c9a327be407e601e03207d8d)
BibTeX
@misc{dcbed120bf57f4,
  title = {Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis — Europe PMC PMID:42449587},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449587},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bed120bf57f4; sha256 1934cb46664c15e80649dc8285df1cc8da004f34c9a327be407e601e03207d8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449587. Agents can read the archived copy with the MCP tool read_document.